Newborns with harlequin ichthyosis require management in a neonatal intensive care unit. 
Ensure that the patient's airway, breathing, and circulation are stable after delivery. Early intubation may be required.  Babies require intravenous access. Peripheral access may be difficult and umbilical cannulation may be necessary. Place infants in a humidified incubator. Monitor temperature, respiratory rate, heart rate, and oxygen saturation. Once stabilized, transfer newborn with harlequin ichthyosis to a NICU.
Exposure keratitis results from ectropion of the eyelids. Apply ophthalmic lubricants frequently to protect the conjunctivae. 
Bathe infants twice daily and use frequent wet sodium chloride compresses followed by application of bland lubricants to soften hard skin. Dilute bleach baths may reduce the risk of skin infection. 
Topical keratolytics (eg, salicylic acid) are not recommended in newborns because of potential systemic toxicity.
According to Rajpopat et al, early retinoid treatment (by day 7) may require prompt consideration, as these medications can take some days to obtain.  See Medication.
Intravenous fluids are almost always required.  Consider excess cutaneous water losses in daily fluid requirement calculations. Monitor serum electrolyte levels. A risk of hypernatremic dehydration exists.
Neonates with harlequin ichthyosis initially do not feed well and may require tube feeding. 
Maintain a sterile environment to avoid infection. Take frequent cultures of the skin. Growth of pathogenic organisms (eg, Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella) indicates risk of sepsis. Draw blood cultures because sepsis can occur quickly in affected infants.
Further inpatient care
Continue careful attention to skin care and use of emollients during retinoid therapy.
Infants with harlequin ichthyosis can be successfully breastfed or bottle-fed as the eclabium improves.  Involving occupational therapy to aid in feeding strategies is advised. Carefully monitor weight gain and intake. Affected infants are at risk of failure to thrive.
Physical bonding between the parents and the baby should be encouraged.
Early formation of a multidisciplinary team is recommended and may include the following:
Complications in the neonatal period include the following:
Dehydration, hypernatremia, hypocalcemia, hypoglycemia
Limb or digital constriction, ischemia
Infants who survive the newborn period have a lifelong, severe ichthyosiform erythroderma.
Recurrent skin infections may continue after the newborn period.
Contractures and painful fissuring of the hands and the feet may occur. Rajpopat et al reported palmoplantar keratoderma in 52% of survivors, causing pain and delay in walking. 
Pruritus was reported in 44% of patients, heat and cold intolerance was found in 36%, reduced sweating was found in 28%, and photosensitivity and pigmented macules were found in one patient each.  Poor hair growth and nail deformities were common. Hearing impairment may result from obstruction of the ear canals by skin debris.
Developmental delay and normal intellectual development are described. Rajpopat et al reported that most school-aged survivors were attending mainstream schools, although many needed additional help. 
Growth must be closely monitored. Short stature is common and weight below average. Nutritional rickets due to vitamin D deficiency is reported.  This is likely due to defective vitamin D synthesis in the abnormal skin, calcium loss, and reduced exposure to sunlight.
Infants are discharged from the hospital when their cutaneous symptoms are improving, feeding and weight gain are established, and they are free of infection.
Social and psychological support should be provided for the parents/caregivers. 
The primary care physician should closely monitor the infants for growth, development, social issues, and skin surveillance. A dermatologist should monitor affected infants for ongoing assessment and for monitoring of retinoid therapy.
Adverse effects of retinoid therapy (eg, mucocutaneous dryness, aberrant liver function tests, hypertriglyceridemia, benign intracranial hypertension) should be noted. Serum AST, ALT, total cholesterol, and triglyceride levels should initially be obtained on a monthly basis initially. The clinician should be cognizant of the musculoskeletal abnormalities that can occur with long-term retinoid therapy, if treatment is continued.
Follow-up with an ophthalmologist is required. Recurrent exposure keratitis can be a problem as a result of persistent ectropion.
What would you like to print?